Phanstiel S. Louise
- SEC CIK
- 0001471518
In the past year, 3 open-market purchase filings worth $2.06M and no sales.
Current role at each company
- BFLY Butterfly Network, Inc.Directoras of Aug 17, 2026
- MYGN Myriad Genetics IncDirectoras of Jun 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $2.06M
- 3 filings
- Sold
- –
- 0 filings
- Net
- +$2.06M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Phanstiel S. Louise as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BFLY Butterfly Network, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 (view filing)4:51 PM ET | Aug 14 | 3 days | Phanstiel S. LouiseDirector | PPurchaseClass A Common Stock | +115.2K | $8.68 | +$999.5K | +62.2%300.5K after | |
| Dec 17, 2025 (view filing) | Dec 15 | 2 days | Phanstiel S. LouiseDirector | PPurchaseClass A Common Stock | +185.3K | $3.08 | +$570.6K | New position185.3K after | |
| Sep 13, 2024 (view filing) | Sep 13 | Same day | Phanstiel S. LouiseDirector | SSaleClass A Common Stock | −60.0K | $1.96 | −$117.7K | −100.0%0 after |
MYGN Myriad Genetics Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 (view filing) | Feb 25-27 | 2 days | Phanstiel S. LouiseDirector | PPurchase | +104.5K | $4.73 | +$494.5K | +58.9%282.0K after | 3 lots |
| Aug 6, 2021 (view filing) | Aug 5 | 1 day | Phanstiel S. LouiseDirector | SSale | −47.9K | $35.04 | −$1.68M | −43.7%61.6K after |